Skip to main content

Complex Regional Pain Syndrome (CRPS)

0
Pipeline Programs
3
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Abbott
AbbottABBOTT PARK, IL
1 program
Dorsal Root GanglionN/A1 trial
Active Trials
NCT02800863Completed426Est. Sep 2021
Arctic Therapeutics
Arctic TherapeuticsIceland - Reykjavik
1 program
Individualized CRPS RehabilitationN/A1 trial
Active Trials
NCT02753335Recruiting12Est. Nov 2032

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Arctic TherapeuticsIndividualized CRPS Rehabilitation
AbbottDorsal Root Ganglion

Clinical Trials (2)

Total enrollment: 438 patients across 2 trials

NCT02753335Arctic TherapeuticsIndividualized CRPS Rehabilitation

Clinical and Cerebral Changes Following Multifaceted Rehabilitation of Complex Regional Pain Syndrome

Start: Sep 2016Est. completion: Nov 203212 patients
N/ARecruiting
NCT02800863AbbottDorsal Root Ganglion

TARGET Post-Approval Study

Start: Aug 2016Est. completion: Sep 2021426 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 438 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.